Clinical Cell Culture renames

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.

The resolution to change the company's name was passed by the vast majority of shareholders.

Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.

The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd